Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees.

Prescription Weight Loss Drugs: Types, Side Effects and How to Choose U.S. News & World Report June 17, 2025, 8:00 PM ...

COLUMBUS, Ohio (WCMH) — A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees.

MHRA launches genetic study into GLP-1 drug risks as Spain investigates Novo Nordisk for potential advertising violations.

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...